CAPTRUST FINANCIAL ADVISORS

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1512024 RALEIGH, NC

Position in PACB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$94,854

+$36,352 QoQ

Shares Held

56,461

+27.4% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 222 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 59% Shared 0% None 41%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $194,335,431 across 52 Medical Devices names. PACB ranks #40 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	509,302	$46,214,063
2	STE	STERIS plc	209,519	$44,118,415
3	SYK	Stryker Corp	138,667	$43,657,918
4	MDT	Medtronic plc	258,603	$20,230,512
5	EW	Edwards Lifesciences Corp	60,926	$5,511,365
6	BSX	Boston Scientific Corp	123,736	$5,281,052
7	DXCM	Dexcom Inc	47,517	$3,200,269
8	GEHC	GE HealthCare Technologies Inc.	47,861	$3,063,582

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$94,854	56,461	+27.4%	Shares	Sole	2026-08-13
2026-03-31	$58,502	44,320	+3.2%	Shares	Sole	2026-05-15
2025-12-31	$80,333	42,959	+215.8%	Shares	Sole	2026-02-17
2023-12-31	$133,445	13,603	+5.7%	Shares	Sole	2024-02-14
2023-09-30	$107,439	12,867	+11.0%	Shares	Sole	2023-11-15
2023-06-30	$154,160	11,591	+646.4%	Shares	Sole	2023-08-15
2022-06-30	$6,864	1,553	-20.1%	Shares	Sole	2022-08-23
2022-03-31	$17,681	1,943	+89.7%	Shares	Sole	2022-05-16
2021-12-31	$20,951	1,024	-58.2%	Shares	Sole	2022-02-14
2021-09-30	$62,648	2,452	+6.2%	Shares	Sole	2021-11-16
2021-06-30	$80,710	2,308	-12.4%	Shares	Sole	2021-08-16
2021-03-31	$87,771	2,635	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.